Rosuvastatin and salts thereof free of rosuvastatin...

Details Rosuvastatin and salts thereof free of rosuvastatin... Rosuvastatin and salts thereof free of rosuvastatin...

2009-03-11

2011-11-22

Jarrell, Noble (Department: 1622)

Organic compounds -- part of the class 532-570 series

Organic compounds

Nitrogen attached directly or indirectly to the purine ring...

C544S332000

Reexamination Certificate

active

08063211

ABSTRACT:
The present invention provides rosuvastatin and intermediates thereof having a low level of alkylether impurity and processes for the preparation thereof.

REFERENCES:
patent: 4231938 (1980-11-01), Monaghan et al.
patent: 4346227 (1982-08-01), Terahara et al.
patent: 4444784 (1984-04-01), Hoffman et al.
patent: 4739073 (1988-04-01), Kathawala
patent: 5006530 (1991-04-01), Angerbauer et al.
patent: 5177080 (1993-01-01), Angerbauer et al.
patent: 5202029 (1993-04-01), Haytko et al.
patent: 5260440 (1993-11-01), Hirai et al.
patent: 5354772 (1994-10-01), Kathawala
patent: 5354879 (1994-10-01), Konoike et al.
patent: 5554613 (1996-09-01), Mallion
patent: RE37314 (2001-08-01), Hirai et al.
patent: 6316460 (2001-11-01), Creekmore et al.
patent: 6333198 (2001-12-01), Edmeades et al.
patent: 6777552 (2004-08-01), Niddam-Hildesheim et al.
patent: 6858618 (2005-02-01), Raza et al.
patent: 2005/0080134 (2005-04-01), Niddam-Hildesheim et al.
patent: 2005/0131066 (2005-06-01), Niddam-Hildesheim et al.
patent: 2005/0159615 (2005-07-01), Lifshitz-Liron et al.
patent: 2005/0222415 (2005-10-01), Kumar et al.
patent: 2006/0258882 (2006-11-01), Niddam-Hildesheim et al.
patent: 2007/0037979 (2007-02-01), Niddam-Hildesheim et al.
patent: 2007/0179166 (2007-08-01), Niddam-Hildesheim et al.
patent: 1 872 841 (2006-12-01), None
patent: 0 554 455 (1993-08-01), None
patent: 0 850 902 (1998-07-01), None
patent: 0 521 471 (2000-10-01), None
patent: 1 816 126 (2007-08-01), None
patent: 07 118233 (1995-05-01), None
patent: WO 00/17150 (2000-03-01), None
patent: WO 00/49014 (2000-08-01), None
patent: WO 01/60804 (2001-08-01), None
patent: WO 03/016317 (2003-02-01), None
patent: WO 03/032995 (2003-04-01), None
patent: WO 03/087112 (2003-10-01), None
patent: WO 03/097614 (2003-11-01), None
patent: WO 2004/014872 (2004-02-01), None
patent: WO 2004/052867 (2004-06-01), None
patent: WO 2004108691 (2004-12-01), None
patent: WO 2005/021511 (2005-03-01), None
patent: WO 2005/023778 (2005-03-01), None
patent: WO 2005/040134 (2005-05-01), None
patent: WO 2005/056534 (2005-06-01), None
patent: WO 2005/077916 (2005-08-01), None
patent: WO 2006/035277 (2006-04-01), None
patent: WO 2006/067456 (2006-06-01), None
patent: WO 2006/079611 (2006-08-01), None
patent: WO 2006/091770 (2006-08-01), None
patent: WO 2006 100689 (2006-09-01), None
patent: WO 2006/106526 (2006-10-01), None
patent: WO 2006/136407 (2006-12-01), None
patent: WO 2006/136408 (2006-12-01), None
patent: WO 2007/007119 (2007-01-01), None
patent: WO 2007/041666 (2007-04-01), None
patent: WO 2007/099561 (2007-09-01), None
McTaggart etal. American Journal of Cardiology, 2001, 87 (suppl), pp. 288-328.
Anelli, et al., “Fast and Selective Oxidation of Primary Alcohols to Aldehydes or to Carboxylic Acids and of Secondary Alcohols to Ketones Mediated by Oxoammonium Salts Under Two-Phase Conditions”,J. Org. Chem., 1987, pp. 2559-2562, vol. 52, No. 12.
Greene, “Protective Groups in Organic Synthesis”, John Wiley & Sons, Inc., 1981.
Hull, et al., “Quantification of Rosuvastatin in Human Plasma by Automated Solid-Phase Extraction Using Tandem Mass Spectrometric Detection”,Journal of Chromatography B: Biomedical Sciences&Applications, 2002, pp. 219-228, vol. 772, No. 2.
Konoike, et al. “Practical Synthesis of Chiral Synthons for the Preparation of HMG-CoA Reductase Inhibitors” J. Org. Chem., vol. 59, 1994, pp. 7849-7854.
Lenz, et al., “Tetra-N-Propylammonium Perruthenate (TPAP)-Catalysed Oxidations of Alcohols Using Molecular Oxygen As a Co-Oxidant”,J. Chem. Soc., Perkin Trans. 1, 1997, 3291-3292.
Ley, et al.,Synthesis, 1994, 639-666.
Lipid Research Clinics Program, “The Lipid Research Clinics Coronary Primary Prevention Trial Results: I. Reduction in Incidence of Coronary Heart Disease”,J.A.M.A., 1984, 351-74, vol. 251, No. 3.
Mehta, T.N. et al, Determination of Rosuvastatin in the Presence of Its Degradation Products by a Stability-Indicating LC Method, Journal of AOAC International, Arlington, VA, US, vol. 88, No. 4, Jul. 2005, pp. 1142-1147.
Ohrlein, et al., “Chemo-Enzymatic Approach to Statin Side-Chain Building Blocks”, Adv. Synth. Catal., 2003, pp. 713-715, vol. 345.
Sane, R.T. et al, Determination of Rosuvastatin Calcium in Its Bulk Drug and Pharmaceutical Preparations by High-Performance Thin-Layer Chromatography: JPC. Journal of Planar Chromatography, Moder TLC, Huethig, Heidelberg, DE, vol. 18, No. 103, May 2005, pp. 194-198.
Scandinavian Simvastatin Survival Study Group, “Randomised Trial of Cholesterol Lowering in 4444 Patients With Coronary Heart Disease: The Scandinavian Survival Study (4s)”,The Lancet, 1994, pp. 1383-1389. vol. 344.
Snyder, et al.,Introduction to Modem Liquid Chromatography, 2nd ed., John Wiley & Sons: New York, 1979, pp. 549, 552, 571-572.
Strobel, et al.,Chemical Instrumentation: A Systematic Approach, 3rded., Wiley & Sons: New York, 1989, pp. 391-393, 879, 894, 922, 924-925, 953.
Szantay, et al., “Synthesis of Novel HMG-CoA Reductase Inhibitors, Naphthalene Analogs of Mevinolin”, Liebigs Ann. Chem., 1992, pp. 145-157.
Wantanabe, et al., “Synthesis and Biological Antivity of Methanesulfonamide Pyramidine-and N-Methanesulfonyl Pyrrole-Substituted 3,5-Dihydroxy-6-Heptenoates, A Novel Series of HMG-CoA Reductase Inhibitors”,Bioorganic&Medicinal Chemistry, 1997, pp. 437-444, vol. 5, No. 2.
Witztum, “Chapter 36: Drugs Used in the Treatment of Hyperlipoproteinemias”,Goodman&Gilman's The Pharmacological Basis of Therapeutics, 9thed., pp. 875-897, 1996.

Affiliated with

Also associated with

Rating

Rosuvastatin and salts thereof free of rosuvastatin... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Rosuvastatin and salts thereof free of rosuvastatin..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Rosuvastatin and salts thereof free of rosuvastatin... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4287929